DABIGATRAN ETEXILATE 110 MG CP

Dabigatran Etexilate
$0.9221per EA

Strength

110 mg/1

NDC

67877062460

Classification

Generic

Dosage Form

CAPSULE, COATED PELLETS

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208040

On Market Since

9/12/2025

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-9.5%

3M

-27.4%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-42.6%